Flexion Therapeutics to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference
November 05 2020 - 4:30PM
Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that
Michael Clayman, M.D., President and Chief Executive Officer, will
participate in an analyst-led fireside chat at the 29th Annual
Credit Suisse Virtual Healthcare Conference. The virtual
fireside chat is scheduled to begin at 8:45 a.m. ET on Wednesday,
November 11, 2020.
To access the live webcast of the presentation,
please visit the Flexion website
at http://ir.flexiontherapeutics.com.
About Flexion TherapeuticsFlexion
Therapeutics (Nasdaq:FLXN) is a biopharmaceutical company focused
on the development and commercialization of novel, local therapies
for the treatment of people with musculoskeletal conditions,
beginning with osteoarthritis, the most common form of arthritis.
The Company's core values are focus, ingenuity, tenacity,
transparency and fun. Visit flexiontherapeutics.com.
Contact:
Scott YoungVice President, Corporate Communications
& Investor RelationsFlexion Therapeutics, Inc.T:
781-305-7194syoung@flexiontherapeutics.com
Flexion Therapeutics (NASDAQ:FLXN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Flexion Therapeutics (NASDAQ:FLXN)
Historical Stock Chart
From Apr 2023 to Apr 2024